These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36975592)

  • 1. Lipoprotein(a) and Its Autoantibodies in Association with Calcific Aortic Valve Stenosis.
    Burdeynaya AL; Afanasieva OI; Ezhov MV; Klesareva EA; Saidova MA; Pokrovsky SN
    Diseases; 2023 Mar; 11(1):. PubMed ID: 36975592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Variation in LPA, Calcific Aortic Valve Stenosis in Patients Undergoing Cardiac Surgery, and Familial Risk of Aortic Valve Microcalcification.
    Perrot N; Thériault S; Dina C; Chen HY; Boekholdt SM; Rigade S; Després AA; Poulin A; Capoulade R; Le Tourneau T; Messika-Zeitoun D; Trottier M; Tessier M; Guimond J; Nadeau M; Engert JC; Khaw KT; Wareham NJ; Dweck MR; Mathieu P; Pibarot P; Schott JJ; Thanassoulis G; Clavel MA; Bossé Y; Arsenault BJ
    JAMA Cardiol; 2019 Jul; 4(7):620-627. PubMed ID: 31141105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autotaxin interacts with lipoprotein(a) and oxidized phospholipids in predicting the risk of calcific aortic valve stenosis in patients with coronary artery disease.
    Nsaibia MJ; Mahmut A; Boulanger MC; Arsenault BJ; Bouchareb R; Simard S; Witztum JL; Clavel MA; Pibarot P; Bossé Y; Tsimikas S; Mathieu P
    J Intern Med; 2016 Nov; 280(5):509-517. PubMed ID: 27237700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies and immune complexes to oxidation-specific epitopes and progression of aortic stenosis: Results from the ASTRONOMER trial.
    Capoulade R; Chan KL; Mathieu P; Bossé Y; Dumesnil JG; Tam JW; Teo KK; Yang X; Witztum JL; Arsenault BJ; Després JP; Pibarot P; Tsimikas S
    Atherosclerosis; 2017 May; 260():1-7. PubMed ID: 28319871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of Autotaxin With Lipoprotein(a) in Patients With Calcific Aortic Valve Stenosis.
    Bourgeois R; Devillers R; Perrot N; Després AA; Boulanger MC; Mitchell PL; Guertin J; Couture P; Boffa MB; Scipione CA; Pibarot P; Koschinsky ML; Mathieu P; Arsenault BJ
    JACC Basic Transl Sci; 2020 Sep; 5(9):888-897. PubMed ID: 33015412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Mild to Moderate Aortic Valve Stenosis Progression With Higher Lipoprotein(a) and Oxidized Phospholipid Levels: Secondary Analysis of a Randomized Clinical Trial.
    Capoulade R; Yeang C; Chan KL; Pibarot P; Tsimikas S
    JAMA Cardiol; 2018 Dec; 3(12):1212-1217. PubMed ID: 30476957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prevalence of Lipoprotein(a) Measurement and Degree of Elevation Among 2710 Patients With Calcific Aortic Valve Stenosis in an Academic Echocardiography Laboratory Setting.
    Wilkinson MJ; Ma GS; Yeang C; Ang L; Strachan M; DeMaria AN; Tsimikas S; Cotter B
    Angiology; 2017 Oct; 68(9):795-798. PubMed ID: 28068801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein-associated phospholipase A2 activity, genetics and calcific aortic valve stenosis in humans.
    Perrot N; Thériault S; Rigade S; Chen HY; Dina C; Martinsson A; Boekholdt SM; Capoulade R; Le Tourneau T; Messika-Zeitoun D; Engert JC; Wareham NJ; Clavel MA; Pibarot P; Smith JG; Schott JJ; Mathieu P; Bossé Y; Thanassoulis G; Arsenault BJ
    Heart; 2020 Sep; 106(18):1407-1412. PubMed ID: 32636298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Lipoprotein(a) measured in routine clinical care and the association with incident calcified aortic valve stenosis during a 14-year observational period.
    Wodaje T; Littmann K; Häbel H; Bottai M; Bäck M; Parini P; Brinck J
    Atherosclerosis; 2022 May; 349():175-182. PubMed ID: 35277251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein Proteomics and Aortic Valve Transcriptomics Identify Biological Pathways Linking Lipoprotein(a) Levels to Aortic Stenosis.
    Bourgeois R; Bourgault J; Despres AA; Perrot N; Guertin J; Girard A; Mitchell PL; Gotti C; Bourassa S; Scipione CA; Gaudreault N; Boffa MB; Koschinsky ML; Pibarot P; Droit A; Thériault S; Mathieu P; Bossé Y; Arsenault BJ
    Metabolites; 2021 Jul; 11(7):. PubMed ID: 34357353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of C-reactive protein levels on lipoprotein(a)-associated aortic stenosis incidence and progression.
    Girard A; Gaillard E; Puri R; Capoulade R; Chan KL; Paulin A; Manikpurage HD; Dumesnil J; Tam JW; Teo KK; Couture C; Wareham NJ; Clavel MA; Stroes ESG; Mathieu P; Thériault S; Tsimikas S; Pibarot P; Boekholdt SM; Arsenault BJ
    Eur Heart J Open; 2023 Mar; 3(2):oead032. PubMed ID: 37077580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a), Oxidized Phospholipids, and Aortic Valve Microcalcification Assessed by 18F-Sodium Fluoride Positron Emission Tomography and Computed Tomography.
    Després AA; Perrot N; Poulin A; Tastet L; Shen M; Chen HY; Bourgeois R; Trottier M; Tessier M; Guimond J; Nadeau M; Engert JC; Thériault S; Bossé Y; Witztum JL; Couture P; Mathieu P; Dweck MR; Tsimikas S; Thanassoulis G; Pibarot P; Clavel MA; Arsenault BJ
    CJC Open; 2019 May; 1(3):131-140. PubMed ID: 32159096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The current landscape of lipoprotein(a) in calcific aortic valvular disease.
    Hsieh G; Rizk T; Berman AN; Biery DW; Blankstein R
    Curr Opin Cardiol; 2021 Sep; 36(5):542-548. PubMed ID: 34397461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of serum lipoprotein(a) level with the severity and prognosis of calcific aortic valve stenosis: a Chinese cohort study.
    Liu SL; Rozi R; Shi HW; Gao Y; Guo YL; Tang YD; Li JJ; Wu NQ
    J Geriatr Cardiol; 2020 Mar; 17(3):133-140. PubMed ID: 32280329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a new prediction model for calcific aortic valve stenosis.
    Chen JY; Zhu MZ; Xiong T; Wang ZY; Chang Q
    J Thorac Dis; 2022 Oct; 14(10):4044-4054. PubMed ID: 36389293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid antibodies in patients with calcific aortic valve stenosis.
    Plunde O; Svenungsson E; Ferrannini G; Franco-Cereceda A; Bäck M
    Rheumatology (Oxford); 2023 Mar; 62(3):1187-1196. PubMed ID: 35961031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a) and calcific aortic valve stenosis: A systematic review.
    Prog Cardiovasc Dis; ; . PubMed ID: 32526213
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.